NA
TGAN

NewEdge Advisors’s Transphorm, Inc. Common Stock TGAN Stock Holding History

NewEdge Advisors’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$491 – 4043
2024
Q1 		$491 Hold
100
– – ﹤0.01% 3586
2023
Q4 		$365 Hold
100
– – ﹤0.01% 3562
2023
Q3 		$222 Hold
100
– – ﹤0.01% 3317
2023
Q2 		$340 Hold
100
– – ﹤0.01% 3347
2023
Q1 		$399 Hold
100
– – ﹤0.01% 3261
2022
Q4 		$1 Buy
+100
New +$588 ﹤0.01% 4061

NewEdge Advisors's TGAN Position: Q2 2024 in Review

NewEdge Advisors sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 100 shares — an estimated $491 sold.

NewEdge Advisors first reported a position in TGAN in Q4 2022 and held it in 6 quarters. The position peaked at $491 in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

  • NewEdge Advisors reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • NewEdge Advisors sold 100 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $491.
  • NewEdge Advisors first reported a position in Transphorm, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • NewEdge Advisors's Transphorm, Inc. Common Stock position peaked at $491 in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.